Actively Recruiting

Phase Not Applicable
Age: 4Years - 21Years
All Genders
Healthy Volunteers
ID05150197

Virtual Reality Visual Field Testing as an Alternative to Standard Automated Perimetry in Childhood Eye Disease

Led by Duke University · Updated on 2026-05-26

1000

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate a new method for measuring peripheral vision using a wearable device called VisuALL, which functions as virtual reality goggles. The study compares this new test to the standard Humphrey Visual Field (HVF) test commonly used in eye exams. It involves both healthy children and young adults, as well as those with eye conditions requiring visual field testing as part of their usual care. Participants will either undergo both the standard HVF test and the VisuALL test or only the VisuALL test during a regular eye appointment. Selected participants may also receive training and be loaned a VisuALL device to perform visual field testing at home. The tests do not involve touching the eyes or using eye drops and are considered safe with no known risks aside from potential confidentiality concerns. During the study visit, which takes about 30 minutes, various visual field results will be measured, including mean deviation, pattern standard deviation, and sensitivity. Researchers will also assess the ability to use the VisuALL device both in-office and at home, as well as participant satisfaction through questionnaires. There is no extra cost to participate, and parking is compensated on the visit day. The study will continue until July 2028.

CONDITIONS

Brief Title

Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease

Who Can Participate

Age: 4Years - 21Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients must be at least four (4) years old
  • Cognitively normal (no developmental delay or syndrome)
  • Be able to tolerate wearing the virtual reality goggles for at least 10 minutes
  • Be able to provide informed consent of a parent/guardian (and assent if 12 years or older)
  • Do not have any ocular diseases that could interfere with the visual field testing
Not Eligible

You will not qualify if you...

  • Developmental delay
  • Inability to obtain consent
  • Inability to understand English

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Diagnostic Evaluation

Duration - 1 day

Participants undergo visual field testing using both the standard Humphrey Visual Field test and the VisuALL Virtual Reality Visual Field device to assess visual field parameters.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Duke University Medical Center

Durham, North Carolina, United States, 27705

Actively Recruiting

Loading map...

Research Team

S

Sharon F Freedman, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Similar Trials

Visual Field Expansion Through Innovative Multi-Periscopic P...

Hemianopia, Homonymous

Actively Recruiting

1 location

Hemianopsia Rehabilitation After Stroke or Brain Injury

Hemianopsia

Actively Recruiting

1 location

Visual Restoration of Losses Caused by Cortical Damage: a Ne...

Visual Field Defect, Peripheral

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Preliminary Report on a Novel Virtual Reality Perimeter Compared With Standard Automated Perimetry.

Reza Razeghinejad, Alberto Gonzalez-Garcia, Jonathan S Myers...

https://pubmed.ncbi.nlm.nih.gov/32941320